Sample Size Calculation for Thorough QT/QTc Study Considering Various Factors Related to Multiple Time Points

REFERENCES

• Berger , R. , Hsu , J. ( 1996 ). Bioequivalence trials, intersection-union tests and equivalence confidence sets . Stat. Sci. 11 : 283 – 319 .
   Web of Science ®Google Scholar
• Barbey , J. T. , Pezzullo , J. C. , Soignet , S. L. ( 2003 ). Effect of arsenic trioxide on QT interval in patients with advanced malignancies . J. Clin. Oncol. 21 : 3609 – 3615 .
   PubMed Web of Science ®Google Scholar
• Boos , D. , Hoffman , D. , Kringle , R. , Zhang , J. (2007). New confidence bounds for QT studies. Stat. Med. 26:3801–3817.
   PubMed Web of Science ®Google Scholar
• Chow , S. C. , Cheng , B. , Cosmatos , D. ( 2008 ). On power and sample size calculation for QT studies with recording replicates at given time point . J. Biopharm. Stat. 18 ( 3 ): 483 – 493 .
   PubMed Web of Science ®Google Scholar
• Hommel , G. ( 1986 ). Multiple test procedures for arbitrary dependence structures . Biom. J. 25 : 423 – 430 .
   Google Scholar
• Hosmane , B. , Locke , C. ( 2005 ). A simulation study of power in thorough QT/QTc studies and a normal approximation for planning purposes . Drug Information J. 39 : 447 – 455 .
   Web of Science ®Google Scholar
• Hutmacher , M. M. , Chapel , S. , Agin , M. A. , Joseph , C. , Fleishaker , J. C. , Lalonde , R. L. ( 2008 ). Performance characteristics for some typical QT study designs under the ICH E-14 guidance . J. Clin. Pharmacol. 48 : 215 – 224 .
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonization . ( 2005 ). ICH E-14. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for nonantiarrhythmic drugs . Fed. Reg. 70 : 61134 – 61135 .
   PubMedGoogle Scholar
• International Conference on Harmonization . ( 2008 ). ICH E-14 Implementation Working Group—Questions & Answers. Available at: http://www.ich.org
   Google Scholar
• Jones , B. , Kenward , M. G. ( 2002 ). Design and Analysis of Cross-Over Trials. , 2nd ed. London : Chapman and Hall .
   Google Scholar
• Meng , Z. , Quan , H. , Fan , L. , Kringle , B. , Sun , G. ( 2009 ). Use of the average baseline versus the time-matched baseline in parallel group thorough QT/QTc studies . J. Biopharm. Stat. 20 ( 3 ): 665 – 682 .
   Google Scholar
• Sethuraman , V. , Sun , Q. ( 2008 ). Impact of baseline ECG collection on the planning, analysis and interpretation of ‘thorough’ QT trials . Pharm. Stat. 8 ( 2 ): 113 – 124 .
   Google Scholar
• Senn , S. J. ( 1989 ). The use of baselines in clinical trials of bronchodilators . Stat. Med. 8 : 1339 – 1350 .
   PubMed Web of Science ®Google Scholar
• Tsong , Y. , Zhong , J. , Chen , W. J. ( 2008 ). Validation testing in thorough QT/QTc clinical trials . J. Biopharm. Stat. 18 ( 3 ): 529 – 541 .
   PubMed Web of Science ®Google Scholar
• Wellek , S. ( 2003 ). Testing Statistical Hypotheses of Equivalence . London : Chapman and Hall .
   Google Scholar
• Zhang , D. , Meng , Z. , Hui , Q. ( 2006 ). Sanofi-Aventis. Technical report .
   Google Scholar
• Zhang , J. ( 2008 ). Testing for positive control activity in a thorough QTc study . J. Biopharm. Stat. 18 ( 3 ): 517 – 528 .
   PubMed Web of Science ®Google Scholar
• Zhang , J. , Machado , S. G. ( 2008 ). Statistical issues including design and sample size calculation in thorough QT/QTc studies . J. Biopharm. Stat. 18 ( 3 ): 451 – 467 .
   PubMed Web of Science ®Google Scholar
• Zhang , L. , Dmitrienko , A. , Luta , G. ( 2008 ). Sample size calculations in thorough QT studies . J. Biopharm. Stat. 18 ( 3 ): 468 – 482 .
   PubMed Web of Science ®Google Scholar